TNBC is a subtype of breast cancer that is hormone-receptor negative and human epidermal growth factor receptor 2-negative (Perou et al., 2000), accounting for 15% to 20% of the global incidence of breast cancer (Mayer et al., 2014). This evidence concerns the gene NR4A1 and breast carcinoma.